During the past decade, Arthritis Center of North Georgia conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 9 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 7 clinical trials were completed. i.e. 140% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arthritis Center of North Georgia" #1 sponsor was "R-Pharm International, LLC" with 3 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Galapagos NV" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arthritis Center of North Georgia" #1 collaborator was "OCT Clinical Trials" with 3 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "Biogen" with 1 trials as a collaborator and "IQVIA Pvt. Ltd" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Arthritis Center of North Georgia" are "Rheumatoid Arthritis" (10 trials), "Osteoarthritis, Hip" (2 trials), "Osteoarthritis, Knee" (2 trials), "Chronic Gout" (1 trials) and "Chronic Pain" (1 trials). Many other conditions were trialed in "Arthritis Center of North Georgia" in a lesser frequency.

Most popular intervention types in "Arthritis Center of North Georgia" are "Drug" (14 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Baricitinib" (2 trials), "GLPG0634" (2 trials), "TNF Inhibitor" (2 trials) and "Tanezumab 2.5 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Arthritis Center of North Georgia" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Arthritis Center of North Georgia". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Arthritis Center of North Georgia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Arthritis Center of North Georgia, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".